Home > Financial Ratios > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AAREY DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 11.349.24-25.6820.5517.58

What is the latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS is 11.34 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202511.34
Mar20249.24
Mar2023-25.68
Mar202220.55
Mar202117.58

How is Core EBITDA Growth of AAREY DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 11.34
22.73
Mar2024 9.24
Positive
Mar2023 -25.68
Negative
Mar2022 20.55
16.89
Mar2021 17.58 -

Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AAREY DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS ₹188.7 Cr -0.8% -29.7% 8.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,768.0 Cr -2.7% -2.2% -0.8% Stock Analytics
DIVIS LABORATORIES ₹169,385.0 Cr -0.7% -1.1% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,242.0 Cr -0.8% 0.8% 12.2% Stock Analytics
CIPLA ₹121,093.0 Cr -1.2% -1.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,799.0 Cr NA 2.4% 0.2% Stock Analytics


AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

-0.8%

-29.7%

8.9%

SENSEX

-0.4%

-0.2%

2.9%


You may also like the below Video Courses